ROSEN, A LONGSTANDING FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ANRO

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of common stock of Alto Neuroscience, Inc. due to alleged misleading statements regarding the company's business and product effectiveness during the Class Period from February 2, 2024, to October 22, 2024 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Alto made materially false and misleading statements about its product ALTO-100, particularly regarding its effectiveness in treating major depressive disorder, which led to overstated clinical and commercial prospects [5]. - Investors are encouraged to join the class action lawsuit, with the deadline to serve as lead plaintiff set for September 19, 2025 [1][3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering significant amounts for investors [4]. - The firm has been recognized for its performance in securities class action settlements, including a notable settlement against a Chinese company and securing over $438 million for investors in 2019 alone [4].